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Jasmine Baughman & Dr. Joseph E. Bradshaw
Ouachita Baptist University Department of Chemistry, Arkadelphia, AR 71998-0001
Photodynamic therapy (PDT) is a treatment for various health 
disorders, including cancer, that uses a photosensitive agent 
and light. Unlike other cancer treatments, PDT is a focused 
treatment that kills cancerous cells without harming the 
surrounding tissues. When a photosensitive agent is 
administered, it accumulates in the tumor as it binds to low 
density lipoproteins. When the tumor is exposed to a specific 
wavelength of light, the photosensitive agent is activated; 
this results in the release singlet oxygen, which kills the 
tumor. The objective of this research was to synthesize and 
characterize a novel photosensitive agent, H2TPP-2A2E. 
Purification of the novel be used in the next generation of 
photodynamic therapy. material was achieved using column 
chromatography.  In addition, IR, UV-vis, and NMR 
spectroscopies were used to characterize the product, and 
purity was determined using HPLC. After determining that 
our product was refined, cytotoxicity testing in light and dark 
conditions revealed that the novel H2TPP-2A2E, could 
potentially be used in the next generation of photodynamic 
therapy. 
Figure 1: Standard Porphyrin Core Structure (Unsubstituted)
A standard poryphrin ring structure, 
unsubstituted.
Figure 2: R-Group attached to Porphyrin Core
2-Amino-2-ethyl-1,3-propanediol 
UV-vis Spectroscopy
• Examine the cytotoxicity of H2TPP-2A2E 
among normal cells and other cancer cell 
lines.
• Synthesize additional novel water-soluble 
metallic porphyrin derivatives, such as 
ZnTPP-DIPA, to see if other derivatives are 
more desirable in killing A549 lung cancer 
cells and are, therefore, candidates for PDT.
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• A novel water-soluble porphyrin was 
successfully synthesized.
• The compound was characterized by UV-vis, IR, 
and NMR spectroscopies.
• The spectrums indicate that the correct 
compound has indeed been formed. 
• At concentrations of 100 uM and above, light 
treatment consistently increases cell death, 
whereas treated cells kept in the dark remained 
viable.
• Results conclude that at high concentrations, 
H2TPP-2A2E is an effective photosensitizer. 
• A porphyrins’ usefulness is largely due to its 
conjugated structure, light absorbing qualities, 
and efficacy as photosensitizers.
• Various uses of porphyrins include gene 
regulation, drug and iron metabolism, hormone 
synthesis, electron transfer medium (conducting 
polymers), oxygen transport medium 
(hemoglobin), solar cell (convert light or chemical 
energy), metal binder (ligand). 
• This research specifically utilizes and tests the 
light sensitivity of the porphyrins and how they 
react to cells. 




• A patient diagnosed with a tumor is injected with a 
photosensitizer.
• Due to the nature of the photosensitizer, it collects in 
the tumor over time.
• The tumor is exposed to light for a given amount of 
time, activating the photosensitizer.
• The tumor is selectively destroyed.
• Non-small Cell Lung Cancer Cells 
• The most common form of lung cancer
• Constitutes 84% of all lung cancer diagnoses
• 5 year survival rate is 24% 
Reaction 1
• 4-formylbenzoic acid (2) reacted with pyrrole (1) in a propionic 
acid solution to form H2TPPC (3).
Reaction 3
• The acid chloride porphyrin (4) reacts with diisopropylamine in  
methanol to form , the final product (5).
Reaction 2
• H2TPPC (3) reacts with thionyl chloride in dimethylformamide, 
forming an acid chloride porphyrin (4).














High Performance Liquid Chromatography 




• Light (left) and dark (right)
• H2TPP-2A2E plated on wells 
8-12
• 50 uM, 100 uM, 150 uM, 
200 uM, and 250 uM
concentrations
• Purple is indicative of living 
cells.
• Column 12 of the light plate 
are noticeably lighter in 
color.    
• Correlation between higher concentrations 
of 2A2E and compound toxicity.
• MTT assay results indicate that the exposure 
to light significantly decreases cell viability. 
• The largest difference in cell viability is found 
at a concentration of 250 uM, at which cells 
kept in the dark maintained their original 
viability compared to those exposed to light 
which have 22% viability. 
